Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Reid W Merryman, Brad S Kahl, Robert A. Redd, Jad Bsat, Matthew Lewis Chase, Ann S. LaCasce, Arnold S. Freedman, Caron A. Jacobson, David C. Fisher, Samuel Y. Ng, Jennifer L Crombie, Austin I Kim, Oreofe O. Odejide, Matthew S. Davids, Jennifer R. Brown, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, Amanda F Cashen, Nancy L. Bartlett, Armin Ghobadi, Philippe Armand, Robin M. Joyce, Eric D Jacobsen
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2904897106